The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of ramucirumab (RAM) for metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma across age subgroups in two global phase 3 trials.
 
Kei Muro
Honoraria - Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Jae Yong Cho
No Relationships to Disclose
 
Gyorgy Bodoky
Travel, Accommodations, Expenses - Lilly; Pfizer
 
Chanchal Goswami
No Relationships to Disclose
 
Yee Chao
No Relationships to Disclose
 
Lucas Vieira dos Santos
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Research Funding - Amgen (Inst); Boston Scientific (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Yasuhiro Shimada
Research Funding - Chugai Pharma; Lilly; Taiho Pharmaceutical
 
Eldar Topuzov
No Relationships to Disclose
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Chugai Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche; Sanofi; Symphony Evolution; Taiho Pharmaceutical; Takeda
 
John Raymond Zalcberg
No Relationships to Disclose
 
Ian Chau
Honoraria - Lilly; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Lilly; Macrogenics; MSD Oncology; Sanofi
Research Funding - Janssen-Cilag (Inst); Merck Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Lilly; Merck Serono; MSD; Sanofi
 
Rebecca Cheng
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
 
Yanzhi Hsu
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
 
Michael Emig
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Mauro Orlando
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
 
Hansjochen Wilke
Honoraria - Lilly
Consulting or Advisory Role - Lilly
 
Charles S. Fuchs
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Entrinsic Health; Five Prime Therapeutics; Genentech/Roche; Gilead Sciences; Lilly; Macrogenics; MedImmune; Merck; Pfizer; Sanofi; Takeda